Blog

Plasticell gets funding to develop blood substitute from stem cells – pharmaphorum


pharmaphorum

Plasticell gets funding to develop blood substitute from stem cells
pharmaphorum
Plasticell, a developer of cell therapies including hematopoietic cell replacement therapies, has secured £920,000 from the British government's Innovate UK to create a safe, effective red blood cell substitute for human clinical transfusion. A

2017-04-13 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.